Testosterone for Women: The Overlooked Hormone That Changes Everything

Ask most women about their hormones and they'll mention estrogen, progesterone, and maybe thyroid. Testosterone? That's for men. This thinking is so deeply embedded in both pop culture and most medical training that when a woman walks into a doctor's office with textbook low-testosterone symptoms, she's almost never tested for testosterone, much less treated.

That's a major gap. Women make testosterone too. By 40, most women are producing about half the testosterone they had at 20. By menopause, it drops further. The result is often a collection of symptoms, low libido, flat mood, loss of muscle, mental dullness, fatigue, that never get connected to their hormonal source.

This is the complete 2026 guide to testosterone for women.

Women produce testosterone, and a lot rides on it

Healthy young women produce about 10% of the testosterone men produce. It comes from two sources: the ovaries (making ~25%) and the adrenal glands (making ~25%), with the remaining ~50% converted from precursors like DHEA.

Despite being present at lower levels than in men, testosterone in women drives:

• Libido and sexual desire, the dominant hormone for female sexual drive, arguably more than estrogen
• Energy and motivation, "getting out of bed and into life" drive
• Cognitive function, focus, mental sharpness, spatial reasoning
• Muscle mass and strength, even at female levels, testosterone drives muscle maintenance
• Bone density, alongside estrogen
• Mood and sense of wellbeing, low T is associated with flat mood, irritability, and anhedonia
• Body composition, favors lean mass over fat, supports healthy body fat distribution
• Skin, hair, and vitality

When does female testosterone decline?

Testosterone in women starts declining in the mid-20s and falls steadily from there:

• Levels at 40 are typically about half those at 20
• Levels continue declining through perimenopause
• After natural menopause, testosterone drops further but not dramatically (ovaries still produce some)
• After surgical menopause (oophorectomy), testosterone drops sharply, often by 50% overnight
• Chronic stress, anorexia, overtraining, and some medications all suppress female T further

Signs of low testosterone in women

The classic pattern:

• Low libido, the most common and classic symptom. Not just lower drive, but loss of arousal response and capacity for desire.
• Difficulty reaching orgasm or reduced intensity
• Flat mood, anhedonia, depression that doesn't respond to SSRIs or therapy
• Persistent fatigue
• Loss of muscle tone or difficulty maintaining muscle despite training
• Weight gain, particularly abdominal
• Brain fog, slower processing
• Reduced sense of "getting into life", lack of drive and engagement
• Thinning hair, reduced strength of body hair
• Loss of confidence or assertiveness

How to test testosterone in women properly

This is where most women get failed. Standard lab tests for testosterone are calibrated for male ranges and are often inaccurate in the lower range where women live. Required tests:

• Total testosterone, via LC-MS/MS assay (not immunoassay)
• Free testosterone, calculated or measured directly
• SHBG, critical, as high SHBG binds testosterone and makes total T misleading
• DHEA-S, the adrenal precursor
• Estradiol and progesterone, for context

Optimal ranges for women

Standard reference ranges for women are based on averages that include many women with deficient levels. More useful targets:

• Total testosterone: 40-70 ng/dL (optimal), versus "normal range" that often extends down to 8-10 ng/dL
• Free testosterone: 1.5-3.5 pg/mL (varies by assay)
• SHBG: 40-70 nmol/L, high SHBG sequesters testosterone and can cause symptoms at "normal" totals

Treatment: low-dose testosterone for women

Testosterone therapy for women uses doses roughly 1/10 of male doses. Protocols have shifted toward cleaner, more physiologic approaches over the last few years.

Topical testosterone cream (most common)

Compounded testosterone cream or gel applied daily to the inner thigh, lower abdomen, or vulva (for local effect on libido). Typical doses: 1-5 mg per day. Smooth, daily delivery. Can be titrated easily.

Subcutaneous injection

Low-dose testosterone cypionate 5-10 mg once weekly subcutaneously. More predictable dosing than creams but requires injection. Used more in clinics comfortable with injectable protocols.

Pellet implants

Long-acting pellets implanted every 3-4 months. Popular in women's health clinics but harder to titrate. Often produce supraphysiologic levels early in the cycle.

Oral testosterone

Generally avoided in women due to liver pass-through effects on cholesterol and lipids.

What to expect on testosterone therapy

First 2-6 weeks

Libido and mood often respond first. Many women report "feeling like themselves again" within a month.

2-6 months

Body composition shifts begin. Muscle tone returns. Training capacity improves.

6+ months

Full effect visible. Most women on properly dosed testosterone report significantly improved libido, energy, body composition, and cognitive function.

Side effects and how to manage them

The classic concern about testosterone in women is masculinization. At physiologic doses, matching what a healthy young woman's ovaries produce, this concern is generally unfounded. Side effects that can occur with supraphysiologic dosing:

• Acne, more common at high doses, usually transient
• Increased facial or body hair, dose-dependent, usually subtle
• Voice deepening, rare at proper doses, irreversible if it occurs, which is why monitoring matters
• Clitoral enlargement, also rare at proper doses, can be a sign of over-dosing
• Scalp hair thinning, in women with genetic predisposition

Nearly all of these are prevented by proper dose titration and regular monitoring.

The controversy, why isn't this standard care?

In most countries, testosterone is not FDA-approved for women. The pharmaceutical industry has shown little interest in pursuing approval, the market is considered small relative to development costs. The result is that testosterone therapy for women is:

• Widely prescribed off-label by forward-thinking providers
• Typically using compounded formulations (not FDA-approved brand products)
• Considered the standard of care in specialized women's health practices
• Increasingly recommended by menopause societies worldwide
• Still dismissed or ignored by many primary care and OB/GYN practices

The International Menopause Society and The Menopause Society (North America) both recommend testosterone for women with Hypoactive Sexual Desire Disorder in menopause. Momentum is shifting, but the gap between evidence and practice remains large.

Who benefits most?

• Women with persistent low libido despite well-managed estrogen and progesterone
• Women post-oophorectomy (surgical menopause)
• Postmenopausal women with fatigue, flat mood, and loss of drive
• Women on SSRIs whose libido has been further suppressed
• Active women struggling with recovery, muscle maintenance, and body composition
• Women in their 40s whose T has declined but who aren't yet in full menopause

The bottom line

Testosterone is not a male hormone, it's a human hormone that both sexes need. For women experiencing the classic pattern of low libido, flat mood, fatigue, and loss of drive, especially around or after menopause, low-dose testosterone therapy is often the missing piece that estrogen and progesterone alone can't fill. Tested properly. Dosed properly. Monitored properly. It's one of the highest-leverage conversations in women's health medicine.